Patient Safety Organizations: Voluntary Relinquishment for Symbria SAFE, 59624-59625 [2019-24152]
Download as PDF
59624
Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices
and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than December 5, 2019.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Greene Investment Company,
Jefferson, Iowa; to merge with Perry
Investment Company and thereby
indirectly acquire Raccoon Valley Bank,
both of Perry, Iowa.
Board of Governors of the Federal Reserve
System, October 31, 2019.
Michele Taylor Fennell,
Assistant Secretary of the Board.
[FR Doc. 2019–24130 Filed 11–4–19; 8:45 am]
BILLING CODE 6210–01–P
77 K Street NE, 10th Floor, Washington,
DC 20002
November 13, 2019, 8:30 a.m.
Open Session
1. Approval of the October 28, 2019
Board Meeting Minutes
2. Investment Manager Annual Service
Review
3. Investment Benchmark Update
4. Monthly Reports
(a) Participant Activity Report
(b) Investment Performance
(c) Legislative Report
5. Quarterly Reports
(d) Metrics
6. Office of Resource Management
Annual Report and FEVS Update
Closed Session
Information covered under 5 U.S.C.
552b(c)(6).
Contact Person for More Information:
Kimberly Weaver, Director, Office of
External Affairs, (202) 942–1640.
BILLING CODE 6760–01–P
khammond on DSKJM1Z7X2PROD with NOTICES
GENERAL SERVICES
ADMINISTRATION
[Notice-MA–2019–09; Docket No. 2019–
0002; Sequence No. 26]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
This bulletin reaffirms that
sleeping in buildings under the
jurisdiction, custody or control of GSA,
including those buildings delegated to
other Federal agencies by the
Administrator of General Services, is
prohibited, except when expressly
authorized by an agency official.
Sleeping may be authorized if the
person is directed by a supervisor to
remain in the building to conduct
official government business and it is
necessary for the person to sleep on the
premises or, in the case of an emergency
where there is imminent danger to
human life or property, where persons
are directed to shelter-in-place.
Applicable: November 5, 2019.
FOR FURTHER INFORMATION CONTACT:
Board Member Meeting
[FR Doc. 2019–24085 Filed 11–4–19; 8:45 am]
Notice.
SUMMARY:
DATES:
FEDERAL RETIREMENT THRIFT
INVESTMENT BOARD
Dated: October 30, 2019.
Megan Grumbine,
General Counsel, Federal Retirement Thrift
Investment Board.
ACTION:
Chris Coneeney, Director, Real Property
Policy Division, Office of Governmentwide Policy, GSA at 202–501–2956, or
email realpropertypolicy@gsa.gov.
Please cite FMR Bulletin B–49.
The
Federal Management Regulation (FMR)
does not specifically identify
unauthorized sleeping as a type of
prohibited conduct in subpart C of 41
CFR part 102–74. Instead, agency
officials have relied on provisions in the
FMR that address hazards, disturbances
and failure to comply with the lawful
direction of Federal police officers and
other authorized individuals to prohibit
the practice of unofficially sleeping in
Federal buildings. Since GSA has
received questions regarding the
permissibility of sleeping in Federal
buildings, and the FMR does not
specifically address this conduct, GSA
is issuing this bulletin to reaffirm the
fact that all persons are prohibited from
sleeping in Federal buildings, except
when such activity is expressly
authorized by an agency official. The
Facility Manager will post this bulletin
in a conspicuous place in the building
so that all persons in the building have
constructive or actual notice of the
policy.
SUPPLEMENTARY INFORMATION:
Jessica Salmoiraghi,
Associate Administrator, Office of
Government-wide Policy.
[FR Doc. 2019–24102 Filed 11–4–19; 8:45 am]
BILLING CODE 6820–14–P
Federal Management Regulation
(FMR); Sleeping in Federal Buildings
Office of Government-wide
Policy (OGP), General Services
Administration (GSA).
AGENCY:
VerDate Sep<11>2014
16:34 Nov 04, 2019
Jkt 250001
PO 00000
Frm 00013
Fmt 4703
Sfmt 4703
Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Relinquishment for Symbria
SAFE
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Final Rule
(Patient Safety Rule) authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a patient safety organization (PSO) an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient
Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason, or when a PSO’s
listing expires. AHRQ accepted a
notification of proposed voluntary
relinquishment from Symbria SAFE,
PSO number P0146, of its status as a
PSO, and has delisted the PSO
accordingly.
SUMMARY:
The delisting was effective at
12:00 Midnight ET (2400) on October
31, 2019.
ADDRESSES: The directories for both
listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. Both
directories can be accessed
electronically at the following HHS
website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT:
Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
DATES:
Background
The Patient Safety Act, 42 U.S.C.
299b–21 to 299b–26, and the related
Patient Safety Rule, 42 CFR part 3,
published in the Federal Register on
November 21, 2008, 73 FR 70732–
70814, establish a framework by which
individuals and entities that meet the
definition of provider in the Patient
Safety Rule may voluntarily report
information to PSOs listed by AHRQ, on
a privileged and confidential basis, for
E:\FR\FM\05NON1.SGM
05NON1
Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
the aggregation and analysis of patient
safety events.
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
PSOs.
AHRQ has accepted a notification of
proposed voluntary relinquishment
from Symbria SAFE, a component entity
of Symbria Inc., to voluntarily
relinquish its status as a PSO.
Accordingly, Symbria SAFE, P0146, was
delisted effective at 12:00 Midnight ET
(2400) on October 31, 2019.
Symbria SAFE has patient safety work
product (PSWP) in its possession. The
PSO will meet the requirements of
section 3.108(c)(2)(i) of the Patient
Safety Rule regarding notification to
providers that have reported to the PSO
and of section 3.108(c)(2)(ii) regarding
disposition of PSWP consistent with
section 3.108(b)(3). According to section
3.108(b)(3) of the Patient Safety Rule,
the PSO has 90 days from the effective
date of delisting and revocation to
complete the disposition of PSWP that
is currently in the PSO’s possession.
More information on PSOs can be
obtained through AHRQ’s PSO website
at https://www.pso.ahrq.gov.
Virginia Mackay-Smith,
Associate Director.
[FR Doc. 2019–24152 Filed 11–4–19; 8:45 am]
BILLING CODE 4160–90–P
VerDate Sep<11>2014
16:34 Nov 04, 2019
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting of the National Advisory
Council for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of public meeting.
AGENCY:
This notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality.
DATES: The meeting will be held on
Thursday, November 21, 2019, from
8:30 a.m. to 12:00 p.m.
ADDRESSES: The meeting will be held at
AHRQ, 5600 Fishers Lane, Rockville,
Maryland, 20857.
FOR FURTHER INFORMATION CONTACT:
Jaime Zimmerman, Designated
Management Official, at the Agency for
Healthcare Research and Quality, 5600
Fishers Lane, Mail Stop 06E37A,
Rockville, Maryland 20857, (301) 427–
1456. For press-related information,
please contact Bruce Seeman at (301)
427–1998 or Bruce.Seeman@
AHRQ.hhs.gov.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact the
Food and Drug Administration (FDA)
Office of Equal Employment
Opportunity and Diversity Management
on (301) 827–4840, no later than
Thursday, November 7, 2019. The
agenda, roster, and minutes will be
available from Ms. Heather Phelps,
Committee Management Officer, Agency
for Healthcare Research and Quality,
5600 Fishers Lane, Rockville, Maryland
20857. Ms. Phelps’ phone number is
(301) 427–1128.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Purpose
In accordance with section 10(a) of
the Federal Advisory Committee Act, 5
U.S.C. App., this notice announces a
meeting of the National Advisory
Council for Healthcare Research and
Quality (the Council). The Council is
authorized by Section 941 of the Public
Health Service Act, 42 U.S.C. 299c. In
accordance with its statutory mandate,
the Council is to advise the Secretary of
the Department of Health and Human
Services and the Director of AHRQ on
matters related to AHRQ’s conduct of its
mission including providing guidance
on (A) priorities for health care research,
(B) the field of health care research
including training needs and
PO 00000
Frm 00014
Fmt 4703
Sfmt 4703
59625
information dissemination on health
care quality and (C) the role of the
Agency in light of private sector activity
and opportunities for public private
partnerships. The Council is composed
of members of the public, appointed by
the Secretary, and Federal ex-officio
members specified in the authorizing
legislation.
II. Agenda
On Thursday, November 21, 2019, the
Council meeting will convene at 8:30
a.m., with the call to order by the
Council Chair and approval of previous
Council summary notes. The meeting is
open to the public and will be available
via webcast at
www.webconferences.com/ahrq. The
meeting will begin with an update on
AHRQ’s budget, programs and
initiatives. The agenda will also include
a discussion about the challenges and
opportunities to leverage AHRQ’s CDS
Connect to improve care and a
conversation about the gaps and
opportunities for improving care, with a
focus on social determinants of health.
The meeting will adjourn at 12:00 p.m.
The final agenda will be available on the
AHRQ website at www.AHRQ.gov no
later than Thursday, November 14,
2019.
Dated: October 30, 2019.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2019–24081 Filed 11–4–19; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Reporting of Pregnancy Success Rates
From Assisted Reproductive
Technology (ART) Programs;
Clarifications and Corrections
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces
clarifications for and correction to
certain data collection fields,
terminology, and definitions used for
reporting of pregnancy success rates
from assisted reproductive technology
(ART) programs. This reporting is
required by the Fertility Clinic Success
Rate and Certification Act of 1992
(FCSRCA).
SUMMARY:
E:\FR\FM\05NON1.SGM
05NON1
Agencies
[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Pages 59624-59625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24152]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment for
Symbria SAFE
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to
list as a patient safety organization (PSO) an entity that attests that
it meets the statutory and regulatory requirements for listing. A PSO
can be ``delisted'' by the Secretary if it is found to no longer meet
the requirements of the Patient Safety and Quality Improvement Act of
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses
to voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ accepted a notification of proposed
voluntary relinquishment from Symbria SAFE, PSO number P0146, of its
status as a PSO, and has delisted the PSO accordingly.
DATES: The delisting was effective at 12:00 Midnight ET (2400) on
October 31, 2019.
ADDRESSES: The directories for both listed and delisted PSOs are
ongoing and reviewed weekly by AHRQ. Both directories can be accessed
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the
related Patient Safety Rule, 42 CFR part 3, published in the Federal
Register on November 21, 2008, 73 FR 70732-70814, establish a framework
by which individuals and entities that meet the definition of provider
in the Patient Safety Rule may voluntarily report information to PSOs
listed by AHRQ, on a privileged and confidential basis, for
[[Page 59625]]
the aggregation and analysis of patient safety events.
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of PSOs.
AHRQ has accepted a notification of proposed voluntary
relinquishment from Symbria SAFE, a component entity of Symbria Inc.,
to voluntarily relinquish its status as a PSO. Accordingly, Symbria
SAFE, P0146, was delisted effective at 12:00 Midnight ET (2400) on
October 31, 2019.
Symbria SAFE has patient safety work product (PSWP) in its
possession. The PSO will meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule regarding notification to
providers that have reported to the PSO and of section 3.108(c)(2)(ii)
regarding disposition of PSWP consistent with section 3.108(b)(3).
According to section 3.108(b)(3) of the Patient Safety Rule, the PSO
has 90 days from the effective date of delisting and revocation to
complete the disposition of PSWP that is currently in the PSO's
possession.
More information on PSOs can be obtained through AHRQ's PSO website
at https://www.pso.ahrq.gov.
Virginia Mackay-Smith,
Associate Director.
[FR Doc. 2019-24152 Filed 11-4-19; 8:45 am]
BILLING CODE 4160-90-P